RZLT
Price
$6.30
Change
+$0.43 (+7.33%)
Updated
Jul 25 closing price
Capitalization
548.07M
45 days until earnings call
SMMT
Price
$28.67
Change
+$1.10 (+3.99%)
Updated
Jul 25 closing price
Capitalization
21.29B
9 days until earnings call
Interact to see
Advertisement

RZLT vs SMMT

Header iconRZLT vs SMMT Comparison
Open Charts RZLT vs SMMTBanner chart's image
Rezolute
Price$6.30
Change+$0.43 (+7.33%)
Volume$1.37M
Capitalization548.07M
Summit Therapeutics
Price$28.67
Change+$1.10 (+3.99%)
Volume$1.79M
Capitalization21.29B
RZLT vs SMMT Comparison Chart in %
Loading...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RZLT vs. SMMT commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RZLT is a Buy and SMMT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (RZLT: $6.30 vs. SMMT: $28.67)
Brand notoriety: RZLT and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RZLT: 112% vs. SMMT: 42%
Market capitalization -- RZLT: $548.07M vs. SMMT: $21.29B
RZLT [@Biotechnology] is valued at $548.07M. SMMT’s [@Biotechnology] market capitalization is $21.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RZLT’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 2 green FA rating(s).

  • RZLT’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 2 green, 3 red.
According to our system of comparison, SMMT is a better buy in the long-term than RZLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RZLT’s TA Score shows that 5 TA indicator(s) are bullish while SMMT’s TA Score has 6 bullish TA indicator(s).

  • RZLT’s TA Score: 5 bullish, 4 bearish.
  • SMMT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than RZLT.

Price Growth

RZLT (@Biotechnology) experienced а +16.88% price change this week, while SMMT (@Biotechnology) price change was +9.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

RZLT is expected to report earnings on Sep 11, 2025.

SMMT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($21.3B) has a higher market cap than RZLT($548M). SMMT YTD gains are higher at: 60.661 vs. RZLT (28.571). RZLT has higher annual earnings (EBITDA): -77.12M vs. SMMT (-235.08M). SMMT has more cash in the bank: 361M vs. RZLT (86.9M). RZLT has less debt than SMMT: RZLT (1.78M) vs SMMT (6.45M). RZLT (0) and SMMT (0) have equivalent revenues.
RZLTSMMTRZLT / SMMT
Capitalization548M21.3B3%
EBITDA-77.12M-235.08M33%
Gain YTD28.57160.66147%
P/E RatioN/A26.41-
Revenue00-
Total Cash86.9M361M24%
Total Debt1.78M6.45M28%
FUNDAMENTALS RATINGS
RZLT vs SMMT: Fundamental Ratings
RZLT
SMMT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
9332
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3737
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (53) in the null industry is somewhat better than the same rating for SMMT (95) in the Biotechnology industry. This means that RZLT’s stock grew somewhat faster than SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (32) in the Biotechnology industry is somewhat better than the same rating for RZLT (93) in the null industry. This means that SMMT’s stock grew somewhat faster than RZLT’s over the last 12 months.

SMMT's SMR Rating (98) in the Biotechnology industry is in the same range as RZLT (98) in the null industry. This means that SMMT’s stock grew similarly to RZLT’s over the last 12 months.

SMMT's Price Growth Rating (37) in the Biotechnology industry is in the same range as RZLT (37) in the null industry. This means that SMMT’s stock grew similarly to RZLT’s over the last 12 months.

SMMT's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for RZLT (100) in the null industry. This means that SMMT’s stock grew significantly faster than RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RZLTSMMT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMCJX50.600.21
+0.42%
Touchstone Mid Cap C
SXPCX51.910.20
+0.39%
DWS S&P 500 Index C
NMVZX12.480.04
+0.32%
Nuance Mid Cap Value Z
FVRLX6.300.01
+0.16%
Forester Value R
DAINX20.830.01
+0.05%
Dunham International Stock A

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+7.33%
RLAY - RZLT
47%
Loosely correlated
+1.63%
XNCR - RZLT
45%
Loosely correlated
N/A
SYRE - RZLT
41%
Loosely correlated
+1.08%
ATYR - RZLT
41%
Loosely correlated
+4.95%
SMMT - RZLT
41%
Loosely correlated
+3.99%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+3.99%
BCDA - SMMT
69%
Closely correlated
+1.73%
TIL - SMMT
54%
Loosely correlated
-1.71%
BNTX - SMMT
53%
Loosely correlated
+0.65%
RLAY - SMMT
47%
Loosely correlated
+1.63%
FHTX - SMMT
44%
Loosely correlated
N/A
More